Butyrate: The Microbiome's Anti-Aging "Kill Switch" for Senescent Cells

News
#162

A new fiber-related paper:

The Acid Test for Longevity: How Fermenting Fiber Lowers Blood Pressure via pH-Sensing Receptors

High blood pressure is a primary driver of cardiovascular mortality and a major hurdle to extending human healthspan. While the cardioprotective effects of dietary fiber are well documented, the underlying mechanisms have traditionally been attributed to the direct cellular absorption of microbial metabolites, specifically short-chain fatty acids (SCFAs). This paper proposes an alternative, biophysical mechanism: fiber fermentation lowers the macroscopic pH of the large intestine, transforming the colon into an acidic reservoir that modulates systemic cardiovascular and immune function via proton-sensing receptors.

SCFAs act as potent proton donors within the gut. High-fiber diets can plunge colonic pH from a neutral ~7.2 down to ~6.0, simultaneously inhibiting the proliferation of pathogenic bacteria and favoring SCFA-producing strains. This acidification functions as an environmental switch, directly activating a specialized family of G protein-coupled receptors (GPCRs)—specifically GPR65 and GPR68—which are highly responsive in the pH 6.2–6.8 range.

GPR65 is primarily localized on immune cells, where its activation suppresses pro-inflammatory cytokine production through cAMP-dependent pathways. GPR68 is expressed in vascular smooth muscle, endothelial, and immune cells, and it mediates flow-dependent vasodilation. When functioning correctly, this pH-driven GPCR axis protects against angiotensin II-induced hypertension. Conversely, emerging clinical data indicate that patients with uncontrolled hypertension exhibit a higher, more alkaline baseline colonic pH.

Actionable Insights To leverage these findings for longevity and cardiovascular optimization, the objective is sustained colonic acidification via continuous microbial fermentation.

  • Prioritize Fermentable Fibers: Consume high volumes of resistant starches, inulin, and galacto-oligosaccharides. These complex carbohydrates bypass small-intestinal digestion, delivering raw substrate to the colon for maximal SCFA conversion.
  • Modulate Microbiome pH Strategically: The optimal colonic pH target is ~6.0. Diets low in fiber alkalize the colon (~7.5), promoting pro-inflammatory taxa. Limit the sustained use of broad-spectrum antibiotics, which rapidly deplete bacterial load and result in severe colonic alkalization (pH > 7.7).
  • Avoid Oral SCFA Shortcuts: Standard oral butyrate supplements are largely absorbed in the small intestine and do not reach the colon. They fail to effectively lower colonic pH or actuate these specific receptor cascades. Deliverability requires either whole-food diet-derived fiber or heavily encapsulated, colon-targeted SCFAs.

Context

4 Likes
#163

Oral Short-Chain Fatty Acids Rescue Memory and Mitigate Hippocampal Atrophy in Aging

The age-related shrinking of the brain—particularly hippocampal atrophy and the subsequent widening of the ventricles—is a core morphological driver of cognitive decline. Interventions targeting the gut-brain axis offer a novel therapeutic window, yet direct quantitative data on brain morphology following targeted metabolite therapy remains sparse. This in vivo study evaluated the chronic administration of Short-Chain Fatty Acids (SCFAs)—acetate, propionate, and butyrate—over a nine-month period.

The findings demonstrate a profound neuroprotective effect. Using 7T Magnetic Resonance Imaging (MRI), researchers mapped massive structural preservation in SCFA-treated cohorts. Most notably, the high-dose intervention prevented hippocampal volume loss, achieving an exceptional effect size (d=2.03) against aged controls, and radically curtailed third ventricle dilation (d=-2.50).

Behaviorally, these structural victories translated into functional cognitive preservation. Both low and high-dose SCFA protocols yielded statistically significant enhancements in short- and long-term memory metrics across the Novel Object Recognition Test and Morris Water Maze, effectively averting typical age-associated spatial memory deficits.

Mechanistically, this neuroprotection was heavily associated with a systemic dampening of innate immune hyperactivation. Treatment successfully downregulated hippocampal Toll-like receptor 4 (TLR4) expression—a primary sentinel for neuroinflammation—and concurrently slashed circulating levels of the pro-inflammatory cytokines TNF-alpha and IL-6. Furthermore, long-term SCFA administration remodeled the gut microbiome, driving a pronounced expansion of Alloprevotella and Clostridiales , which correlated positively with total hippocampal volume. [Confidence: Medium]. This suggests that continuous SCFA exposure can short-circuit the TLR4/NF-kB inflammatory cascades that typically degrade neural architecture over time.

Actionable Insights

While this data relies on the direct ingestion of sodium salts of SCFAs in an animal model, humans can achieve comparable systemic SCFA elevation through targeted dietary engineering. The primary, practical intervention to replicate these neuroprotective effects is the aggressive consumption of fermentable dietary fibers (e.g., inulin, resistant starch, pectin), which act as substrates for colonic microbiota to synthesize acetate, propionate, and butyrate endogenously.

For targeted application, direct butyrate supplementation via liposomal delivery or tributyrin compounds is required to bypass upper gastrointestinal metabolism, ensuring higher bioavailability than standard sodium butyrate. The data strongly suggests that chronic immune modulation through the gut-brain axis is a prerequisite for preserving hippocampal volume. Therefore, integrating high-polyphenol foods (such as pomegranate extract and resveratrol) alongside prebiotics may synergistically enhance SCFA-producing bacterial colonies, specifically Alloprevotella and Clostridia species. Track your systemic inflammation markers—particularly serum TNF-alpha and IL-6—as proxy indicators that your SCFA-enhancing interventions are successfully downregulating TLR4-mediated innate immune aging.

Context

4 Likes
#164

How Butyrate Rescues the Mitochondrial “Engine” to Extend Life

Mitochondrial diseases have long been viewed as internal “power plant” failures, where the DNA inside our cellular engines breaks down, leading to multi-organ collapse. However, a groundbreaking study published in Nature Communications suggests that the path to systemic failure might actually start in the gut. Researchers discovered that when mitochondria fail, they trigger a “gut-microbiota-epigenetic” tailspin that accelerates death—a process that can be dramatically reversed with a simple metabolite: butyrate.

The team developed a sophisticated mouse model (iTfamKO) where mitochondrial function could be “turned off” across the entire body of an adult. These mice quickly developed a progeroid (prematurely aged) syndrome, including muscle wasting (sarcopenia), brain degeneration, and kidney failure. Surprisingly, the earliest signs of trouble appeared in the intestine. The gut barrier broke down, leading to “leaky gut” and a radical shift in the bacterial population. Specifically, beneficial bacteria that produce short-chain fatty acids (SCFAs) like butyrate were wiped out.

This loss of butyrate wasn’t just a side effect; it was a driver of the disease. Butyrate acts as a molecular “remote control” for our DNA, attaching chemical tags (acylation) to histones that tell genes how to behave. Without these tags, the intestinal cells lost their ability to maintain their structure and manage oxidative stress.

The researchers tested two interventions: Fecal Microbiota Transplants (FMT) from healthy donors and direct supplementation with tributyrin , a butyrate precursor. While both helped, direct tributyrin supplementation was the clear winner, extending the maximum lifespan of the mitochondrial-deficient mice by a staggering 75%. By restoring butyrate, the researchers essentially “rebooted” the gut’s genetic programming, which in turn mitigated systemic issues like muscle loss and poor glucose metabolism. This suggests that supporting the gut-mitochondrial axis may be a powerful lever for combatting age-related decline.

Actionable Insights

  • Support the Gut-Mitochondrial Axis: Mitochondrial health and gut integrity are a two-way street. Strategies that support mitochondrial function—such as zone 2 exercise or specific compounds—may be undermined if the gut microbiome is in dysbiosis, particularly if butyrate-producing taxa (e.g., Lachnospiraceae ) are missing.

  • Prioritize Butyrate Precursors: For those with suspected mitochondrial inefficiency, direct supplementation with tributyrin may be more effective than general probiotics or even fecal transplants, as it bypasses the need for successful bacterial colonization in a “hostile” gut environment.

  • Fiber for Epigenetic Health: Butyrate is a primary driver of histone H3 butyrylation , a critical epigenetic mark that regulates genes involved in cell-to-cell junctions and oxidative stress. High-fiber diets that encourage natural SCFA production are a baseline “longevity” requirement to maintain this epigenetic landscape.

  • Monitor Gut Transit: Chronic constipation or altered gut motility can be an early warning sign of mitochondrial decline. Maintaining gut “flow” is essential for the habitat of the very bacteria that produce the butyrate needed to keep the system running.

Context & Impact Evaluation

7 Likes
#165

[/quote]

Still another possible useful supplement that I had not heard of.

For me it would be a better alternative to direct butyrate supplementation because tributyrin does have a lower incidence of gastrointestinal side effects, such as gas and bloating, compared to direct butyrate salts (like sodium butyrate) and BHB (beta-hydroxybutyrate) salts.

3 Likes
#166

How Microbiota-Derived Butyrate Rescues Mitochondrial Decay

Mitochondrial diseases represent some of the most challenging conditions in modern medicine, often leading to progressive multisystemic failure with almost no effective treatment options. New research published in Nature Communications identifies a surprising “invisible” player in the progression of these disorders: the gut microbiome. Researchers discovered that systemic mitochondrial failure—induced by deleting a key transcription factor (TFAM) in adult mice—triggers a catastrophic breakdown of the intestinal barrier and a loss of beneficial gut bacteria.

This “leaky gut” and the resulting microbial imbalance (dysbiosis) led to a sharp decline in short-chain fatty acids (SCFAs), specifically butyrate. The study found that this loss of butyrate was not unique to one model; it was also present in “mtDNA-mutator” mice, which accumulate mutations similarly to human aging. This suggests that mitochondrial dysfunction and gut failure are inextricably linked across different genetic causes.

The breakthrough came when scientists attempted to restore this lost symbiosis. By transplanting fecal microbiota from healthy donors or simply supplementing the diet with tributyrin (a butyrate precursor), they were able to significantly delay organ failure and extend the animals’ lives. Mechanistically, butyrate acts as an epigenetic signal, restoring “histone acylation” marks in the intestine that are essential for maintaining the physical barrier and controlling oxidative stress. Without these marks, the gut becomes permeable, allowing bacterial toxins to leak into the bloodstream and accelerate systemic aging.

By fixing the gut, the researchers improved muscle strength, glucose metabolism, and kidney function, proving that the gut-mitochondria axis is a viable target for longevity interventions. While mitochondrial disease originates in the cells’ power plants, this study “tells it like it is”: the path to survival may be paved through the digestive tract.

Actionable Insights

  • Prioritize the Gut-Mitochondria Axis: Longevity strategies should not focus solely on cellular energy; maintaining intestinal barrier integrity is a mechanical necessity to prevent systemic pro-inflammatory signals.

  • Targeted Supplementation: Tributyrin (TB) serves as a potent, direct precursor to butyrate that bypasses the need for complex bacterial colonization. In mice, it was more effective than fecal transplants at extending maximum lifespan.

  • Epigenetic Restoration: Butyrate is not just fuel; it is a signaling molecule that restores essential histone H3 modifications (H3K9ac, H3K9bu, H3K27bu) required for gut homeostasis.

  • Monitor Surrogates of Decay: Elevated levels of LPS-binding protein (LBP) in the serum serve as a surrogate marker for bacterial translocation and gut barrier breakdown.

  • Dietary Fiber and Prebiotics: Since butyrate-producing bacteria like Lachnospiraceae and Ruminococcaceae are lost during mitochondrial decline, diets rich in fiber that support these taxa are critical for endogenous butyrate production.

Source

1 Like
#167

Gut Rewired: How Microbial Metabolites Physically Reshape the Aging Brain

Recent evidence suggests that the contents of our colon may exert a more direct influence on our cognitive destiny than previously realized. Research published in Current Research in Microbial Sciences (2026) delineates a sophisticated biochemical bridge between gut fermentation and the brain’s “operating system”—its epigenetic landscape. Short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate , are no longer viewed merely as energy sources for gut cells; they are now recognized as potent signaling molecules that cross the blood-brain barrier (BBB) to physically alter gene expression.

The “Big Idea” is that SCFAs act as metabolic epigenetic cues. Butyrate , in particular, functions as a natural histone deacetylase (HDAC) inhibitor. By blocking the enzymes that normally keep DNA tightly coiled and “silenced,” butyrate allows the brain to “unroll” and activate neuroprotective genes involved in synaptic plasticity, neurogenesis, and anti-inflammatory responses. This mechanism is critical in countering the progression of Alzheimer’s (AD) and Parkinson’s (PD) , where the brain’s epigenetic machinery is often “stuck” in a pro-degenerative state.

Furthermore, the paper highlights a novel feedback loop involving histone lactylation. In AD, microglia—the brain’s immune cells—shift toward a glycolytic metabolism, producing excess lactate that “lactylates” histones, thereby locking the cells into a chronic, toxic inflammatory state. SCFAs may interrupt this harmful cycle by restoring mitochondrial efficiency and shifting microglial metabolism back to a protective mode.

Actionable Insights

For individuals seeking to leverage these pathways for longevity and neuroprotection, the practical takeaways focus on substrate availability and microbial diversity:

  • Substrate Loading : Increase intake of diverse complex carbohydrates, specifically hemicellulose, inulin, pectin, and resistant starch , which are the primary precursors for SCFA production.

  • Targeted Probiotics : Supplementing with specific “butyrogenic” strains like Clostridium butyricum or Faecalibacterium prausnitzii has shown the potential to restore gut-derived butyrate levels, which typically decline with age.

  • The Acetate Factor : Acetate can cross the BBB to activate AMPK in the hypothalamus, a central regulator of metabolic health and systemic energy allocation.

  • Barrier Maintenance : SCFAs strengthen both the intestinal barrier and the BBB by upregulating tight junction proteins like ZO-1 and occludin , potentially preventing “leaky brain” syndrome.

Source

  • Open Access Paper: Microbial SCFAs as epigenetic mediators: fine-tuning the gut-brain axis in neurodegenerative disorders
  • Institutions : Affiliated Hospital of Nantong University and Zhejiang University School of Medicine.
  • Country : China.
  • Journal : Current Research in Microbial Sciences.
  • Impact Evaluation : The impact score (CiteScore) of this journal is ~8.0 (projected for 2026), evaluated against a typical high-end range of 0–60+ for top general science; therefore, this is a High impact specialty journal.
2 Likes
#168

My butyrate supplement list:

  1. citrus pectin
  2. Bifidobacterium longum BB536
  3. tributyrin (recently started, no side effects so far)

I have been using Bifidobacterium longum BB536 from Life Extension just because I generally trust them, though Amazon and iHerb have several others that look like a better deal. I take three times their recommended daily dose because their supplement contains only 2 billion CFUs per serving, which is rather low compared to most other brands. After doing some research, I started putting my probiotic capsules into slightly larger enteric-coated capsules. This is the first time that taking a probiotic for some time has had subjectively notable effects.

I did not choose these because I thought they were optimal, but because they are things my aging gut finds tolerable. They seem to be working quite well, as measured by my poop and bowel movements.

AI response to my supplement list:

To effectively stop the decline of butyrate in your gut, the evidence points to tributyrin, citrus pectin, and the probiotic Bifidobacterium longum BB536® as your best-supported options.

  • For a direct butyrate boost: Consider tributyrin, which is specifically designed to deliver butyrate directly to the colon.

  • To stimulate your own production: Citrus pectin is an excellent prebiotic fiber choice, demonstrating a strong ability to increase butyrate levels by feeding beneficial bacteria.

  • For a long-term, supportive shift: Adding B. longum BB536® can help reshape your gut community to naturally favor butyrate production, especially when combined with a fiber-rich diet.

The choice among the leading candidates (tributyrin, citrus pectin, or B. longum BB536®) really depends on your personal preference and how your digestive system reacts.

6 Likes
#169

I’ve tried to figure out how to do this. I don’t think they test for it yet do they?

1 Like
#170

Some source information from Gemini Pro:

Monitoring surrogates of gut “decay” and bacterial translocation through commercial laboratories typically involves measuring LPS-binding protein (LBP), Zonulin, and Intestinal Fatty Acid-Binding Protein (FABP2/I-FABP). While direct serum LBP testing is primarily offered through specialized clinical or research panels, standard commercial labs provide these via specialty branches or partner laboratories.

1. Quest Diagnostics (via Cleveland HeartLab)

Quest Diagnostics provides advanced gut integrity testing primarily through its specialty division, Cleveland HeartLab (CHL). These tests are specifically designed to monitor intestinal barrier breakdown and the resulting systemic inflammation.

  • Intestinal Barrier Assessment (CHL): This panel is the most direct way to monitor the “decay” markers mentioned. It typically includes:
    • Zonulin (Serum): A protein that modulates intestinal permeability by disassembling tight junctions (Giron et al., 2022). High levels are a validated marker for “leaky gut” and increased bacterial translocation.
    • FABP2 / I-FABP (Intestinal Fatty Acid-Binding Protein): A protein specifically located in the mucosal layer of the small intestine. It is released into the circulation upon enterocyte injury, serving as a sensitive marker for the physical “decay” of the gut lining (Hernandez et al., 2025; Zaragoza-García et al., 2023).
  • Test Ordering: These are often ordered through Quest as CHL-specific codes. While standard Quest codes vary by region, the Zonulin (Serum) test is frequently identified by Quest code 94605.

2. Labcorp

Labcorp offers individual markers for monitoring intestinal permeability and the translocation of bacterial components.

  • Zonulin, Family (Serum): Labcorp provides a quantitative serum assay for Zonulin.
    • Test Number: 822765
    • Clinical Utility: Used as a physiological driver of tight junction permeability; elevated levels enable the translocation of bacterial and fungal products into the bloodstream (Giron et al., 2022).
  • Complementary Inflammatory Markers: Labcorp often pairs gut barrier testing with systemic markers of bacterial translocation response, such as High-Sensitivity C-Reactive Protein (hs-CRP) (Labcorp code: 006627), which reflects the systemic inflammation triggered by circulating lipopolysaccharides (Hall et al., 2023).

3. Specialized “Gut Barrier” Panels (Reference Labs)

For direct measurement of LPS-binding protein (LBP) itself—which opsonizes gram-negative bacteria and reflects chronic LPS translocation—practitioners often use reference labs that Quest and Labcorp can act as collection sites for:

  • KBMO Diagnostics Gut Barrier Panel: This is the most comprehensive “surrogate of decay” test. It measures immune responses (IgG/IgA) to four specific markers: LBP, Zonulin, Occludin, and LPS (Endotoxin).
  • Mayo Clinic Laboratories: Often serves as a reference lab for Quest/Labcorp for specific translocation markers. Their LBP test (Code: LBP) measures serum levels as an acute-phase protein that peaks shortly after bacteremia and reflects the liver’s response to gut-derived toxins (Barchetta et al., 2023; Opal et al., 1999).

References

Barchetta, I., Cimini, F. A., Sentinelli, F., Chiappetta, C., Di Cristofano, C., Silecchia, G., Leonetti, F., Baroni, M. G., & Cavallo, M. G. (2023). Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity. International Journal of Molecular Sciences, 24(24), 17174. https://doi.org/10.3390/ijms242417174 Cited by: 34

Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N. F., Koshy, J., Hong, K. Y., Rasmussen, H., Miller, G. E., Bishehsari, F., Balk, R. A., Moy, J. N., Hoh, R., Lu, S., Goldman, A. R., Tang, H.-Y., Yee, B. C., Chenna, A., Winslow, J. W., … Keshavarzian, A. (2022). Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling. JCI Insight, 7(14). https://doi.org/10.1172/jci.insight.164813 Cited by: 86

Hall, D. A., Voigt, R. M., Cantu-Jungles, T. M., Hamaker, B., Engen, P. A., Shaikh, M., Raeisi, S., Green, S. J., Naqib, A., Forsyth, C. B., Chen, T., Manfready, R., Ouyang, B., Rasmussen, H. E., Sedghi, S., Goetz, C. G., & Keshavarzian, A. (2023). An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants. Nature Communications, 14(1). An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants | Nature Communications Cited by: 121

Hernandez, J., Rodriguez, J. B., Trak-Fellermeier, M. A., Galvan, R., Macchi, A., Martinez-Motta, P., & Palacios, C. (2025). Suboptimal vitamin D status and overweight/obesity are associated with gut integrity and inflammation in minority children and adolescents: A cross-sectional analysis from the MetA-bone trial. Nutrition Research, 133, 13–21. Redirecting Cited by: 4

Opal, S. M., Scannon, P. J., Vincent, J.-L., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., & Lemke, J. H. (1999). Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS-Binding Protein in Patients with Severe Sepsis and Septic Shock. The Journal of Infectious Diseases, 180(5), 1584–1589. https://doi.org/10.1086/315093Cited by: 798

Zaragoza-García, O., Castro-Alarcón, N., Pérez-Rubio, G., Falfán-Valencia, R., Briceño, O., Navarro-Zarza, J. E., Parra-Rojas, I., Tello, M., & Guzmán-Guzmán, I. P. (2023). Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study. International Journal of Molecular Sciences, 24(3), 1958. https://doi.org/10.3390/ijms24031958

2 Likes
#171

Try to look for miyarisan clostridium butyricum. Direct producers of butyrate. Not instead of bifidumbacteria, but to add.
Good japanese stuff.

2 Likes
#172

Thanks again RapAdmin for all you do!

Im a 67 year old male. I have always been close to 1.0 for hs-crp. My best/pre test hs-crp was 0.8. After 2 months I redid the test and it dropped to 0.2. My ApoB also dropped alot (avg 101 to 79). The stack mentioned seems to have done its job. Thanks!

Since i did not take GBF (i use daily 1-2 tbsp inulin in coffee and psylium husk in every other day smoothies) and 4-6mg rapamycin per week. Oddly as well ive lost 23lbs (212 → 189) in those 2 months, my latest labs also showed big drop in cholesterol as well (Avg total for years ~225 to 185).

I have also been taking .40ml subcutaneous testosterone injections every 3.5 days. Saw big bulk up from 195 to 212 over the past year working out 3x per week in gym. With weight loss, i have nice definition but the bulk is gone now…

Only other thing I did was give a pint of blood a month before recent blood test. I did not use Acarbose in the past 2 months but have it for huge carb meals.

Im going to dig deeper into the interaction between Rapa and Tributyrin-Max. As below i saw good information about that. I want to dig deeper as it sounds like maybe i need to lessen butyrate during first 2-3 days after rapa…

4 Likes
#173

Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers

" To improve the efficacy of dietary supplements like these, it may be necessary to personalize them according to an individual’s gut microbiota (41). The presence of R. bromii or the C. chartatabidum -related organism suggests whether a gut microbiome would yield increased butyrate concentrations following short-term (2-week) supplementation with RPS (research question 4). Individuals without R. bromii in their gut microbiome may benefit from a probiotic supplementation with R. bromii to increase the likelihood of a butyrogenic response to RPS. There may also be a synergistic effect of combining RPS with both R. bromii and E. rectale to maximize the butyrogenic effect of the supplement. In contrast, microbiomes with high levels of bifidobacteria are less likely to increase butyrate production in response to RPS (or inulin), at least in the short term. In these microbiomes, a different supplement or combination of supplements may be needed, or a longer period of time may be required for the microbiome to respond to the supplement. Such considerations are necessary when attempting to effect a particular change in the highly variable structures of human gut communities."

4 Likes
#174

Infant-Derived Probiotic Fortifies Gut Barriers to Preempt Metabolic Decline in Overweight Adults

The transition from “metabolically healthy obesity” (MHO) to overt metabolic disease is often driven by a silent breakdown in the intestinal barrier. This study, a randomized, double-blind, placebo-controlled trial, investigates whether a specific probiotic strain, Bifidobacterium bifidum BGN4 , can intervene in this process by reinforcing gut integrity and dampening systemic inflammation in adults with excess adiposity.

Excess body fat often alters the gut microbiome, leading to increased intestinal permeability—a condition frequently termed “leaky gut”. This allows endotoxins like lipopolysaccharides (LPS) to enter the bloodstream, triggering chronic low-grade inflammation and disrupting insulin signaling. Researchers at Sookmyung Women’s University found that an 8-week regimen of BGN4 significantly reduced serum zonulin , a primary regulator of tight junctions and a key marker of barrier dysfunction.

Beyond the gut, the intervention produced notable systemic effects. Participants receiving the probiotic showed a significant decrease in TNFa , a pro-inflammatory cytokine, and fasting insulin levels compared to the placebo group. These shifts occurred despite no significant changes in body weight, BMI, or body fat percentage, suggesting that BGN4 acts as a metabolic “stabilizer” rather than a weight-loss agent.

The probiotic also reshaped the microbial landscape, specifically increasing the abundance of the Lactiplantibacillus plantarum group and Prevotella stercorea , while reducing taxa associated with impaired glycemic control like Bacteroides coprocola. While the primary outcome of the study—changes in hs-CRP—did not reach statistical significance, the improvements in zonulin and insulin suggest that BGN4 may provide a preventive window for those at risk of progressing from simple adiposity to metabolic syndrome.

Actionable Insights

  • Strain Specificity and Dosage: The study utilized Bifidobacterium bifidum BGN4 at a daily dose of 9 billion CFU (9×109). Generic “Bifidobacterium” supplements may not yield the same barrier-protective results.

  • Targeting Barrier Integrity: For individuals with excess adiposity, BGN4 appears particularly effective at lowering zonulin levels, suggesting it may be a viable tool for addressing suspected metabolic endotoxemia.

  • Insulin Management: The intervention led to a reduction in fasting insulin by approximately 2.33 uIU/mL in the probiotic group while the placebo group saw an increase, highlighting its potential for early-stage glycemic support.

  • Timeframe Expectations: An 8-week duration is sufficient to observe improvements in gut permeability and inflammatory cytokines, but insufficient for fat loss or significant changes in BMI.

  • Combination Strategy: Given that BGN4 increased other beneficial taxa like L. plantarum , it may work synergistically with fiber or other probiotics known to support short-chain fatty acid (SCFA) production.

Source:

1 Like
#175

having a very hard time resolving the conflict between the high resistant starch content of say black beans or oats and this BJN study. If high RS is this bad for TMAO it would seem that higher CVD would result.

1 Like
#176

I agree… me also. I suspect the best way forward in this area is to do TMAO testing to see how our bodies are responding to increased RS over time.

1 Like
#177

Do you think inulin and psylium husk helped you to lose weight?

1 Like
#178

What brand of citrus pectin do you use?

1 Like
#179

I just eat citrus peel daily, from one mandarin and half an orange. Citrus peel has quite a bit of pectin.

Pectin Quantification in Citrus Peels

1 Like
#180

Wait a second, I thought dude was poisoned. I doubt a healthy diet would have made much a difference LOL

1 Like
#181

What was it that you think contributed to such a big drop. 0.2 is pretty amazing.

1 Like